Ucb SA

Common Name

Ucb

Country

Belgium

Sector

Healthcare

Industry

Biotechnology

Employees

8,600

Ticker

UCB

Exchange

EURONEXT

Website

www.ucb.com

Description

UCB S.A. is a global biopharmaceutical company that focuses on developing innovative medicines and sustainable solutions for patients living with severe diseases. Specializing particularly in the fiel... Show more

Financial Statements of Ucb

Below are the financial statements of Ucb, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of EUR	2024	2023
Non-current assets	—	—
Intangible assets	4.08^a	4.23^a
Goodwill	5.46^a	5.25^a
Property, plant and equipment	1.75^a	1.6^a
Deferred income tax assets	1.02^a	0.8^a
Financial and other assets (including derivative financial instruments)	0.24^a	0.21^a
Total non-current assets	12.56^a	12.1^a
Current assets	—	—
Inventories	1.31^a	1.03^a
Trade and other receivables	1.53^a	1.22^a
Income tax receivables	0.05^a	0.07^a
Financial and other assets (including derivative financial instruments)	0.3^a	0.24^a
Cash and cash equivalents	1.57^a	0.86^a
Assets of disposal group classified as held for sale	0.03^a	0.02^a
Total current assets	4.79^a	3.44^a
Total assets	17.35^a	15.54^a
Equity	—	—
Capital and reserves attributable to UCB shareholders	10.03^a	8.98^a
Non-controlling interests	0^a	0^a
Total equity	10.03^a	8.98^a
Non-current liabilities	—	—
Borrowings	1.54^a	2.1^a
Bonds	1.42^a	0.9^a
Other financial liabilities (including derivative financial instruments)	0.07^a	0.06^a
Deferred income tax liabilities	0.09^a	0.29^a
Employee benefits	0.23^a	0.23^a
Provisions	0.23^a	0.21^a
Trade and other liabilities	0.1^a	0.1^a
Income tax payables	0.11^a	0.07^a
Total non-current liabilities	3.79^a	3.95^a
Current liabilities	—	—
Borrowings	0.06^a	0.04^a
Bonds	0^a	0^a
Other financial liabilities (including derivative financial instruments)	0.13^a	0.02^a
Provisions	0.17^a	0.17^a
Trade and other liabilities	3.02^a	2.31^a
Income tax payables	0.15^a	0.07^a
Liabilities of disposal group classified as held for sale	0^a	0^a
Total current liabilities	3.53^a	2.62^a
Equity and liabilities	—	—
Total liabilities	7.32^a	6.56^a
Total equity and liabilities	17.35^a	15.54^a

Download Data

Verified Sources Behind Ucb’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ucb’s data sources below and access millions more through our Disclosure Search.

a. Ucb's Integrated Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Ucb SA

Financial Statements of Ucb

Verified Sources Behind Ucb’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

CSL Ltd

Sino Biopharmaceutical Ltd

Incyte Corp

Genmab A/S

WuXi Biologics (Cayman) Inc

Blueprint Medicines Corp